PHOTON and PULSAR data presentations demonstrate aflibercept 8 mg led to sustained improvements in vision and anatomic measures of retinal fluid across the 48-week treatment period in both 12- and 16-week dosing regimens TARRYTOWN, N.Y., […]
International panel calls on World Health Organization to adopt uniform global standards to help providers identify and aid victims of trafficking EDISON, N,J., Sept. 30, 2022 /PRNewswire/ — Hackensack Meridian Health, New Jersey’s largest and […]
The end of 2022 and into 2023 will be huge for the company for other reasons. Click here to view original post
“There are simple, yet meaningful, steps each of us can take — regardless of our role — to serve as mental health advocates and allies.” Click here to view original post
Viatris has suffered its second stinging loss in as many weeks in its attempt to challenge Merck’s Januvia and Janumet patents. A federal appeals court on Thursday upheld Merck’s patent rights related to the dihydrogen […]
The organizers said it was being held to update community members on the progress of investigational studies of why there were six cases of Ewing’s sarcoma, a rare childhood cancer, in the Canon-McMillan School District […]
“It really allows the surgeon to kind of have a third arm.” Click here to view original post
Another Covid-19 study is hitting the breaks as a Swiss biotech is pausing its Phase II trial in patients hospitalized with Covid-19. Kinarus Therapeutics announced on Friday that the Data and Safety Monitoring Board (DSMB) […]
And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal to daydream about weekend plans. Our agenda is still shaping […]
NEWTOWN SQUARE, Pa., Sept. 30, 2022 /PRNewswire/ — Kibow Biotech, Inc., a clinical-stage biotechnology company developing live biotherapeutics that target the dysbiosis in patients with CKD, today celebrated a 25-year legacy of dedication to improving […]
Copyright © 2023 Biotech Networks, LLC
